RESUMO
In migrating NRK cells, aPKCs control the dynamics of turnover of paxillin-containing focal adhesions (FA) determining migration rate. Using a proteomic approach (two-dimensional fluorescence difference gel electrophoresis), dynein intermediate chain 2 (dynein IC2) was identified as a protein that is phosphorylated inducibly during cell migration in a PKC-regulated manner. By gene silencing and co-immunoprecipitation studies, we show that dynein IC2 regulates the speed of cell migration through its interaction with paxillin. This interaction is controlled by serine 84 phosphorylation, which lies on the aPKC pathway. The evidence presented thus links aPKC control of migration to the dynein control of FA turnover through paxillin.
Assuntos
Adesão Celular/fisiologia , Movimento Celular/fisiologia , Dineínas/metabolismo , Paxilina/metabolismo , Sequência de Aminoácidos , Animais , Células Cultivadas , Dineínas do Citoplasma , Rim/citologia , Rim/enzimologia , Dados de Sequência Molecular , Fosforilação , RatosRESUMO
The social amoeba Dictyostelium discoideum is increasingly being used as a simple model for the investigation of problems that are relevant to human health. This article focuses on several recent examples of Dictyostelium-based biomedical research, including the analysis of immune-cell disease and chemotaxis, centrosomal abnormalities and lissencephaly, bacterial intracellular pathogenesis, and mechanisms of neuroprotective and anti-cancer drug action. The combination of cellular, genetic and molecular biology techniques that are available in Dictyostelium often makes the analysis of these problems more amenable to study in this system than in mammalian cell culture. Findings that have been made in these areas using Dictyostelium have driven research in mammalian systems and have established Dictyostelium as a powerful model for human-disease analysis.
Assuntos
Dictyostelium , Modelos Animais de Doenças , Proteínas de Protozoários/fisiologia , Animais , Antineoplásicos/farmacologia , Encefalopatias/metabolismo , Centrossomo/fisiologia , Quimiotaxia , Dictyostelium/química , Dictyostelium/genética , Dictyostelium/microbiologia , Dictyostelium/fisiologia , Humanos , Legionella pneumophila/crescimento & desenvolvimento , Doença dos Legionários/metabolismo , Neutropenia/metabolismo , Neutrófilos/citologia , Proteínas de Protozoários/análise , Transdução de Sinais , SíndromeRESUMO
Activation of the mitogen-activated protein kinase (MAPK) cascade gives rise to a neuroprotective effect in a variety of cell types. The bipolar disorder treatment, valproic acid (VPA), increases the activity of this pathway by modulating extracellular signal-regulated kinase 2 (ERK2) phosphorylation through an unknown mechanism. To investigate the molecular basis of this effect, we have used the biomedical model system Dictyostelium discoideum to dissect this signalling pathway. We find that, similar to mammalian systems, VPA causes a transient increase in the activation of the MAPK signalling pathway, as shown by ERK2 phosphorylation. We show that the MAP kinase and phosphatase, protein kinase A (PKA) and glycogen synthase kinase signalling pathways all function in controlling the levels of phospho-ERK2 (pERK2). We find that VPA induces elevated pERK2 levels through attenuation of the PKA signalling pathway. Interestingly, pERK2 levels are also controlled by another bipolar disorder drug, lithium, providing a common effect of these two drugs. This work therefore suggests a conserved pathway in eukaryotes that is targeted by neuroprotective and bipolar disorder drugs and allows us to propose a model for this neuroprotective effect.
Assuntos
Anticonvulsivantes/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Dictyostelium/fisiologia , Sistema de Sinalização das MAP Quinases/fisiologia , Fármacos Neuroprotetores/metabolismo , Ácido Valproico/metabolismo , Animais , Ativação Enzimática , Inibidores Enzimáticos/metabolismo , Transferência Ressonante de Energia de Fluorescência , Quinases da Glicogênio Sintase/metabolismo , Humanos , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Quinases de Proteína Quinase Ativadas por Mitógeno/metabolismo , Proteínas de Protozoários/metabolismo , Receptores de AMP Cíclico/metabolismoRESUMO
The Dictyostelium genome harbors single copy genes for both the catalytic and regulatory subunits of the Ca2+/calmodulin-dependent protein phosphatase calcineurin. Since molecular genetic approaches to reduce the expression of these genes have failed so far, we attempted to pharmacologically target calcineurin activity in vivo by using the recently described calcineurin inhibitor, gossypol. Up-regulation of expression of the gene for the Ca2+-ATPase PAT1 in conditions of Ca2+ stress was reduced by gossypol. Dictyostelium wild-type cells treated with 12.5-100 microM gossypol showed reduced growth rates and impaired development. In addition, cell signalling was affected. A cell line that overproduces the catalytic subunit of calcineurin was more resistant to gossypol.